FMOC-ASP(OTBU)-OH
Suppliers
Names
[ CAS No. ]:
71989-14-5
[ Name ]:
FMOC-ASP(OTBU)-OH
[Synonym ]:
L-Aspartic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 4-(1,1-dimethylethyl) ester
FMOC-L-Asparticacidbeta-tert-butylester
4-tert-Butyl hydrogen N-((9H-fluoren-9-ylmethoxy)carbonyl)-L-aspartate
(2S)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-4-[(2-methyl-2-propanyl)oxy]-4-oxobutanoic acid
MFCD00037131
FMOC-L-Aspartic acid beta-tert-butyl ester
N-α-FMOC-L-aspartic acid β-tert-butyl ester
Fmoc-L-aspartic acid 4-tert-butyl ester
Fmoc-Asp(OtBu)-OH
EINECS 276-251-7
(2S)-4-tert-Butoxy-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-oxobutanoic acid (non-preferred name)
9-fluorenyl-methoxycarbonyl-L-Asp-tert-butyl ester
Chemical & Physical Properties
[ Density]:
1.3±0.1 g/cm3
[ Boiling Point ]:
620.8±55.0 °C at 760 mmHg
[ Melting Point ]:
148-150 °C (dec.)
[ Molecular Formula ]:
C23H25NO6
[ Molecular Weight ]:
411.448
[ Flash Point ]:
329.3±31.5 °C
[ Exact Mass ]:
411.168182
[ PSA ]:
101.93000
[ LogP ]:
5.16
[ Vapour Pressure ]:
0.0±1.9 mmHg at 25°C
[ Index of Refraction ]:
1.576
[ Storage condition ]:
2~8°C
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2924299090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2924299090
[ Summary ]:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles
J. Nucl. Med. 56(1) , 113-9, (2015)
Tumor-specific targeting ligands were recently exploited to deliver both imaging and therapeutic agents selectively to cancer tissues in vivo. Because the cholecystokinin 2 receptor (CCK2R) is overexp...
Sci. Rep. 4 , 6777, (2014)
Amyloid-β (Aβ) is one of the few neuropathological biomarkers associated with transporters of the blood-brain barrier (BBB). Despite the well-characterized clinical indication of decreasing Aβ levels ...